This finding points to the TGF-β mechanistic pathway in PCa progression (Li et al. 2008) and warrants further investigation as a therapeutic target by controlling upstream molecular regulators (Huang et al. 2019). Here, TGFB1 is linked to posterior cortical atrophy.